Humanigen, Inc. (HGEN) financial statements (2022 and earlier)

Company profile

Business Address 830 MORRIS TURNPIKE
SHORT HILLS, NJ 07078
State of Incorp. DE
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments, including:70,01667,7372148857372,9068,431
Cash and cash equivalents70,01667,7371438147372,9068,431
Other undisclosed cash, cash equivalents, and short-term investments  7171   
Restricted cash and investments 707070 101200
Receivables    1,400  
Intangible current assets 20     
Other undisclosed current assets955385168344(587)1,5421,763
Total current assets:70,97168,2124521,2991,5504,54910,394
Noncurrent Assets
Property, plant and equipment   (216)1968288
Restricted cash and investments 707171101101193
Other noncurrent assets90     271
Other undisclosed noncurrent assets 20 216   
Total noncurrent assets:90907171120169752
TOTAL ASSETS:71,06168,3025231,3701,6704,71811,146
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities64,58018,5418,3545,9856,6374,808 
Accounts payable44,69813,0785,0462,8563,3304,072 
Accrued liabilities19,882      
Employee-related liabilities 5,4633,3083,1293,307736 
Deferred revenue4,1451,874 
Debt  1,0941,471   
Due to related parties  2,000    
Deferred revenue and credits18,0183,016 
Other undisclosed current liabilities  2,146807   
Total current liabilities:68,72520,41513,5948,26324,6557,824 
Noncurrent Liabilities
Long-term debt and lease obligation25,006 1,247 1,3511,273 
Long-term debt, excluding current maturities25,006 1,247 1,3511,273 
Liabilities, other than long-term debt1,0182,342     
Deferred revenue1,0182,342 
Other undisclosed noncurrent liabilities   1,217   
Total noncurrent liabilities:26,0242,3421,2471,2171,3511,273 
Other undisclosed liabilities      5,414
Total liabilities:94,74922,75714,8419,48026,0069,0975,414
Stockholders' equity
Stockholders' equity attributable to parent(23,688)45,545(14,318)(8,110)(24,336)(4,379)5,732
Common stock645211411015154
Additional paid in capital587,327419,923270,463266,381238,246236,216219,319
Accumulated deficit(611,079)(374,430)(284,895)(274,601)(262,597)(240,610)(213,591)
Total stockholders' equity:(23,688)45,545(14,318)(8,110)(24,336)(4,379)5,732
TOTAL LIABILITIES AND EQUITY:71,06168,3025231,3701,6704,71811,146

Income statement (P&L) ($ in thousands)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
Revenues3,595312     
Gross profit:3,595312     
Operating expenses(236,367)(88,510)(8,944)(11,331)(19,031)(18,825)(34,352)
Operating loss:(232,772)(88,198)(8,944)(11,331)(19,031)(18,825)(34,352)
Nonoperating income (expense)(1,613)(1)(1)324431125(184)
Investment income, nonoperating      29
Other nonoperating income (expense)(1,613)(1)(1)324431125(213)
Interest and debt expense(2,264)(1,336)(1,349)(852)(3,056)(131)(842)
Net loss:(236,649)(89,535)(10,294)(11,859)(21,656)(18,831)(35,378)
Other undisclosed net loss attributable to parent   (145)(331)(8,188) 
Net loss available to common stockholders, diluted:(236,649)(89,535)(10,294)(12,004)(21,987)(27,019)(35,378)

Comprehensive Income ($ in thousands)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
Net loss:(236,649)(89,535)(10,294)(11,859)(21,656)(18,831)(35,378)
Comprehensive loss:(236,649)(89,535)(10,294)(11,859)(21,656)(18,831)(35,378)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent   (145)(331)(8,188)8
Comprehensive loss, net of tax, attributable to parent:(236,649)(89,535)(10,294)(12,004)(21,987)(27,019)(35,370)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: